Most polio virus infections are silent. Vaccination reduces the incidence of infection, and the period between clinical cases of poliomyelitis becomes longer. As the point of eradication is approached, it becomes increasingly difficult to use the case-free period to determine whether silent infections have ceased. In this paper, the authors use stochastic computer simulations to relate case-free periods to the presence or absence of silent infections. After 2 years without paralytic cases in a population of 200,000 inhabitants, the probability for the presence of silent infections can still be as high as 38%. The case-free period must exceed 3 years before one can be 95% certain that there has been local extinction of the wild polio virus infection. Even after 5 years without cases, the probability of silent polio virus transmission can still be in the range of 0.1-1.0%.
The Somalian Ali Maow Maalin was the last person to be naturally infected with the smallpox virus. Except for some laboratory infections, no smallpox cases have been reported since October 26, 1977. Therefore, the World Health Organization was able to declare in 1979 that smallpox has been eradicated throughout the world (1) . If worldwide eradication of poliomyelitis succeeds, then the very last person to be infected with wild polio virus will surely not be known as most individuals develop no clinical signs after infection. Vaccination reduces the incidence of polio virus infection and therefore increases the interval between clinical cases. Long intervals between cases of paralysis present difficulties in determining whether transmission of the wild polio virus infection has ceased. This is of practical importance for the plan of global eradication as well as for local vaccination campaigns.
The present study uses stochastic computer simulations based on epidemiologic models to determine how long the case-free period must be before one can draw the conclusion that extinction has occurred with a specified error probability.
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MATERIALS AND METHODS
For details of the simulation procedure, see the Appendix and (2). The following parameter values are intended to represent the situation in a developing country. The population is homogeneously mixing and grows at a constant rate of 2 percent per year. The initial population size is set at 200,000 inhabitants. The average life expectancy is 45 years. The basic reproduction number, i.e., the number of secondary cases that one case could generate in a completely susceptible population, is 12 for the wild polio virus infection. (This number is derived from age-specific antibody data (3-5); a survey of estimation procedures is given in (6).) If a susceptible individual contacts an infectious person, he or she becomes infectious after an incubation period of 1 week. Unless otherwise stated, one in 200 infections leads to paralytic poliomyelitis. The average duration of the infectious period is 1 month (7, 8) . After loss of infectivity, the individual becomes completely and permanently immune. The transition from the incubating state to the infective state and from the infective state to the immune state is modeled as a two-step process. This has no influence on the infectivity of the individual but allows simulation of more realistic distributions for the incubation and infectious periods (for details see Appendix).
Newborn infants are susceptible unless they are vaccinated. Vaccination is performed immediately after birth. Two different vaccines are considered: the inactivated polio virus vaccine and the oral polio virus vaccine.
Inactivated polio virus vaccine (IPV)
Only a fraction of the vaccinated infants become fully immune. The remaining infants are only partially protected against infection and, upon infection, the infectious period is decreased (9, 10) . Following a wild virus infection, a partially susceptible individual becomes completely immune. It is assumed that 70 percent are only partially protected after IPV vaccination. The probability that a contact leads to the infection of a partially protected individual is reduced to 50 percent. The duration of the infectious period is then reduced to 20 percent. All individuals who are successfully vaccinated (both partially and fully immune) will never develop paralytic poliomyelitis.
Oral polio virus vaccine (OPV)
Infants who are successfully vaccinated become infectious with the vaccine virus and can spread it to contacts (10) . Vaccine virus infectivity is lost at the same rate as wild virus infectivity (11, 12) and causes full and permanent protection against infection and disease. The basic reproduction number of the vaccine virus infection is assumed to be a quarter of that of the wild virus infection.
Unless stated otherwise, the simulations start at the endemic equilibrium (without vaccination) of the underlying deterministic model (see Appendix) and are terminated after 10 years. The time between two consecutive epidemiologic events (birth, infection, and the transition from the incubating to the infective state or from the infective to the immune state) and the type of the event are calculated with random numbers (see Appendix for details). At the onset of infectivity, a new random number is chosen to determine whether the infected person becomes ill. It is assumed that a clinical case occurred shortly before the start of the simulations. On a monthly basis, the times since the last paralytic case and the presence or absence of wild polio virus infection are recorded. Finally, the probability that an observed case-free period of length t coincides with the absence of wild polio virus infection is calculated by dividing the number of all casefree periods of length t without wild virus transmission by the total number of case-free periods of length t of all the simulations.
RESULTS
Starting at the endemic equilibrium of wild polio virus infection in a population of 200,000 inhabitants, 60 percent of the newborn infants are effectively vaccinated with OPV or 80 percent with IPV. Extinction of wild polio infection occurs at a frequency of 87.2 and 75.1 percent within 10 years of OPV and IPV vaccination, respectively (studies that address the probability of extinction for different vaccination strategies will be published elsewhere). Tables 1 and 2 show the case-free periods for which the probability of wild polio virus extinction reaches the 95 percent level. The ratio of cases to infections is most influential on the results: If one in 100 infections leads to a paralytic case, the necessary duration of the case-free period is only about 2 years, whereas it is more than 3.5 years if only one in 400 infections leads to a paralytic case. The second most influential parameter is the effective vaccination coverage: Greater coverage results in more reliable case-free periods. The vaccination parameters determine the amount of herd immunity and therefore influence the results in the same way as the vaccination coverage. The wild virus basic reproduction number R w and the demographic parameters have a surprisingly small influence on the outcome. Variation in the simulation time or in the initial number of infective and immune individuals also has little effect on the outcome (results not shown).
DISCUSSION
According to the World Health Organization (13), there must have been a period of 3 years when active surveillance revealed neither cases of poliomyelitis nor circulation of wild polio viruses before local extinction of polio virus infection could be claimed. According to the simulation results, the probability of local extinction reaches 95 percent after case-free periods of about 3 years. This result strongly depends on the case-infection ratio, on the effective vaccination coverage, and on the type of vaccine (tables 1 and 2). According to Fox et al. (14) , the fraction of contacts that lead to paralytic poliomyelitis could be much lower than the standard value of one in 200 that was used. Polio virus infection would then be recognized less often, and the probability that a case-free period was a reliable sign of extinction would be much lower (tables 1 and 2).
It is assumed in our simulations that no infections enter the study population from outside. A reintroduced wild polio virus infection can spread unrecognized for several months or for more than a year in a population with a high vaccination coverage (unpublished results). Another important factor that is not considered in the simulation studies is the age-dependent risk of paralysis. Adults and adolescents are at a greater risk of developing the disease than children 
R,/R w t(%)
Case-free period (years) Life expectancy (years) Case-free period (years) Case-free period (years) * One parameter of the basic set of parameters is varied. Additional parameters are 1) the duration of the infectious period of partially protected individuals (from the inactivated polio virus vaccine) is reduced to 20%, 2) trie duration of the incubation is 1 week, and 3) the full duration of infectivity is 1 month.
t Column of basic parameters. tR w , basic reproduction number of the wild polio virus.
and infants (15). In a country with highly endemic polio virus transmission, most adolescents and adults are immune as a result of infection during childhood.
Vaccinations reduce the spread of polio virus, and so the average age of infection increases. Because of this, the fraction of infections that leads to paralytic poliomyelitis also increases. This unpleasant effect has the consequence that infections become recognized more often, and the absence of paralytic cases becomes a more reliable sign of local extinction. If older children are vaccinated rather than newborns, then many of the polio infections occur within the prevaccination age groups. In this case, infections only rarely cause clinical signs and therefore are recognized less often.
Other factors not included in the models are seasonality and spatial factors that affect the spread of the infection.
The results suggest that a case-free period of 3 years is only borderline sufficient to declare local extinction with a 5 percent error probability. Depending on vaccination coverage and strategy, some locations might require case-free periods of 3.5-4 years. As long as polio virus infection can possibly be imported from abroad, polio vaccination must not be discontinued. 
IPV model equations
where R w = /38
) is the basic reproduction number of the wild virus infection and R v -bR w is the basic reproduction number of the vaccine virus infection.
Short description of the simulation procedure
The deterministic models provide the basis for the simulated stochastic models. The kind of epidemiologic events and the duration between two consecutive events are calculated using random numbers. The simulations start at the endemic equilibrium without vaccination (the numbers of susceptible and infective individuals are rounded to integers). In each simulation step, the sum £ of all the rates that change the current state of the system is calculated. For the OPV model, it is £ = birth rate + death rate + infection rates + transition rates for incubation and infectivity, A uniformly distributed random number r e[0,l] is then chosen, and the time T --ln(r)/£ after which the next event occurs is calculated. All transition rates are arranged in an arbitrary order, and cumulative rates are calculated by adding their individual rates. A new uniformly distributed random number r e[0,£] is chosen, and the first transition in the order whose cumulative rate is larger than r is performed. For example, if the event is an infection, one "individual" is removed from the group of susceptible individuals and added to the group of incubating individuals. New rates are calculated after each step, and the procedure is repeated. A more detailed description of the transformation of differential equation models to stochastic models can be found in (2) .
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